StonvexLoading…
StonvexStonvexStonvexCore line items from BKU's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $21.73M | $20.23M | $20.91M | $22.51M |
Operating Income | $361.75M | $316.35M | $237.08M | $375.13M |
Net Income | $268.35M | $232.47M | $178.67M | $284.97M |
EPS (Diluted) | $3.53 | $3.08 | $2.38 | $3.54 |
Total Assets | $35.04B | $35.24B | $35.76B | $37.03B |
Total Liabilities | $31.99B | $32.43B | $33.18B | $34.59B |
Cash & Equivalents | $217.78M | $491.12M | $588.28M | $572.65M |
Free Cash Flow OCF − CapEx | Not available | Not available | Not available | Not available |
Shares Outstanding | 74.14M | 74.75M | 74.37M | 75.67M |